Bristol Exiting Oncology Distribution Business Ahead Of Part B Pinch
Executive Summary
Bristol-Myers Squibb has signed an agreement to sell its Oncology Therapeutics Network unit prior to the 2005 reimbursement changes for chemotherapy drugs under the Medicare Rx law
You may also be interested in...
Wholesaler Service Fees Exempt From ASP Calculation, CMS Says
Wholesaler service fees paid by pharmaceutical manufacturers are exempt from average sales price calculations, the Centers for Medicare & Medicaid Services says
AmerisourceBergen Still Bullish On Medicare Rx; Part B Changes Pinch
AmerisourceBergen expects to feel a negative impact from the changes in oncology reimbursement under Medicare Part B in 2005
Cymbalta Labeling Hints At Side Effect Claim; Lilly Will Test In Phase IV
Lilly's post-marketing research plans for the antidepressant Cymbalta may help the company establish a claim concerning the drug's effect on female sexual dysfunction